Works matching IS 00333158 AND DT 2005 AND VI 179 AND IP 1

Results: 32

Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 310, doi. 10.1007/s00213-004-2025-1
By:
- Kellner, Michael;
- Muhtz, Christoph;
- Stark, Kristina;
- Yassouridis, Alexander;
- Arlt, Josef;
- Wiedemann, Klaus
Publication type:
Article
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 303, doi. 10.1007/s00213-004-1982-8
By:
- Krystal, John H.;
- Abi-Saab, Walid;
- Perry, Edward;
- D'Souza, D. Cyril;
- Nianjin Liu;
- Gueorguieva, Ralitza;
- McDougall, Lisa;
- Hunsberger, Tracy;
- Belger, Aysenil;
- Levine, Louise;
- Breier, Alan
Publication type:
Article
A six-month, placebo-controlled trial ofd-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 144, doi. 10.1007/s00213-004-2032-2
By:
- Goff, Donald C.;
- Herz, Lawrence;
- Posever, Thomas;
- Shih, Vivian;
- Guochuan Tsai;
- Henderson, David C.;
- Freudenreich, Oliver;
- Evins, A. Eden;
- Yovel, Iftah;
- Hui Zhang;
- Schoenfeld, David
Publication type:
Article
Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 230, doi. 10.1007/s00213-004-2023-3
By:
- Yap, Jasmine J.;
- Covington III, Herbert E.;
- Gale, Melissa C.;
- Datta, Rupak;
- Miczek, Klaus A.
Publication type:
Article
Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 198, doi. 10.1007/s00213-004-2056-7
By:
- Steckler, Thomas;
- Lavreysen, Hilde;
- Oliveira, Ana M.;
- Aerts, Nancy;
- Van Craenendonck, Hansfried;
- Prickaerts, Jos;
- Megens, Anton;
- Lesage, Anne S. J.
Publication type:
Article
Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 172, doi. 10.1007/s00213-004-2054-9
By:
- Dunn, Justin M.;
- Inderwies, Brian R.;
- Licata, Stephanie C.;
- Pierce, R. Christopher
Publication type:
Article
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 247, doi. 10.1007/s00213-004-2069-2
By:
- Kenny, Paul J.;
- Boutrel, Benjamin;
- Gasparini, Fabrizio;
- Koob, George F.;
- Markou, Athina
Publication type:
Article
The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 255, doi. 10.1007/s00213-004-2070-9
By:
- Paterson, Neil E.;
- Markou, Athina
Publication type:
Article
Effects of deletion ofgria1orgria2genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 164, doi. 10.1007/s00213-004-2071-8
By:
- Mead, Andy N.;
- Brown, Geraldine;
- Le Merrer, Julie;
- Stephens, David N.
Publication type:
Article
Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 284, doi. 10.1007/s00213-004-2098-x
By:
- Linden, A.-M.;
- Shannon, H.;
- Baez, M.;
- Yu, J. L.;
- Koester, A.;
- Schoepp, D. D.
Publication type:
Article
Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 151, doi. 10.1007/s00213-004-2110-5
By:
- Schmitt, H. Peter
Publication type:
Article
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 154, doi. 10.1007/s00213-004-2065-6
By:
- Black, Mark D.
Publication type:
Article
Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 181, doi. 10.1007/s00213-004-2055-8
By:
- O'Neill, Michael F.;
- Sanger, Graham;
- Ornstein, Paul L.;
- Osborne, David J.;
- Woodhouse, Sandra M.
Publication type:
Article
Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU2/3 receptor agonist LY379268.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 68, doi. 10.1007/s00213-004-2127-9
By:
- Greco, Barbara;
- Invernizzi, Roberto W.;
- Carli, Mirjana
Publication type:
Article
Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 99, doi. 10.1007/s00213-004-2068-3
By:
- Murphy, Emily R.;
- Dalley, Jeffrey W.;
- Robbins, Trevor W.
Publication type:
Article
Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 292, doi. 10.1007/s00213-004-2126-x
By:
- Spinelli, Simona;
- Ballard, Theresa;
- Gatti-McArthur, Silvia;
- Richards, Grayson J.;
- Kapps, Martin;
- Woltering, Thomas;
- Wichmann, Jurgen;
- Stadler, Heinz;
- Feldon, Joram;
- Pryce, Christopher R.
Publication type:
Article
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 136, doi. 10.1007/s00213-004-2066-5
By:
- Hyun-Sang Cho;
- D'Souza, Deepak C.;
- Gueorguieva, Ralitza;
- Perry, Edward B.;
- Madonick, Steven;
- Karper, Laurence P.;
- Abi-Dargham, Anissa;
- Belger, Aysenil;
- Abi-Saab, Walid;
- Lipschitz, Deborah;
- Bennet, Alexandre;
- Seibyl, John P.;
- Krystal, John H.
Publication type:
Article
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 207, doi. 10.1007/s00213-005-2143-4
By:
- Varty, Geoffrey B.;
- Grilli, Mariagrazia;
- Forlani, Angelo;
- Fredduzzi, Silva;
- Grzelak, Michael E.;
- Guthrie, Donald H.;
- Hodgson, Robert A.;
- Lu, Sherry X.;
- Nicolussi, Elisa;
- Pond, Annamarie J.;
- Parker, Eric M.;
- Hunter, John C.;
- Higgins, Guy A.;
- Reggiani, Angelo;
- Bertorelli, Rosalia
Publication type:
Article
Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 128, doi. 10.1007/s00213-004-2067-4
By:
- Zakharova, E. S.;
- Danysz, W.;
- Bespalov, A. Y.
Publication type:
Article
Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 77, doi. 10.1007/s00213-004-2109-y
By:
- Egerton, Alice;
- Reid, Lee;
- McKerchar, Clare E.;
- Morris, Brian J.;
- Pratt, Judith A.
Publication type:
Article
Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 108, doi. 10.1007/s00213-005-2144-3
By:
- Ferretti, Valentina;
- Florian, Cédrick;
- Costantini, Vivian J. A.;
- Roullet, Pascal;
- Rinaldi, Arianna;
- De Leonibus, Elvira;
- Oliverio, Alberto;
- Mele, Andrea
Publication type:
Article
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 262, doi. 10.1007/s00213-005-2175-9
By:
- Schroeder, Jason P.;
- Overstreet, David H.;
- Hodge, Clyde W.
Publication type:
Article
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 271, doi. 10.1007/s00213-004-2099-9
By:
- Johnson, Michael P.;
- Barda, David;
- Britton, Thomas C.;
- Emkey, Renee;
- Hornback, William J.;
- Jagdmann, G. Erik;
- McKinzie, David L.;
- Nisenbaum, Eric S.;
- Tizzano, Joseph P.;
- Schoepp, Darryle D.
Publication type:
Article
Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 240, doi. 10.1007/s00213-005-2142-5
By:
- Page, Michelle E.;
- Szeliga, Paul;
- Gasparini, Fabrizio;
- Cryan, John F.
Publication type:
Article
Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson’s disease.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 117, doi. 10.1007/s00213-005-2202-x
By:
- Turle-Lorenzo, Nathalie;
- Breysse, Nathalie;
- Baunez, Christelle;
- Amalric, Marianne
Publication type:
Article
Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 4, doi. 10.1007/s00213-005-2200-z
By:
- Kew, James N. C.;
- Kemp, John A.
Publication type:
Article
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 218, doi. 10.1007/s00213-005-2211-9
By:
- Ballard, Theresa M.;
- Woolley, Marie L.;
- Prinssen, Eric;
- Huwyler, Jörg;
- Porter, Richard;
- Spooren, Will
Publication type:
Article
Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 85, doi. 10.1007/s00213-005-2203-9
By:
- Higgins, Guy A.;
- Ballard, Theresa M.;
- Enderlin, Michel;
- Haman, Marie;
- Kemp, John A.
Publication type:
Article
Modulators of the glycine site on NMDA receptors,d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 54, doi. 10.1007/s00213-005-2210-x
By:
- Lipina, Tatiana;
- Labrie, Viviane;
- Weiner, Ina;
- Roder, John
Publication type:
Article
N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 30, doi. 10.1007/s00213-005-2199-1
By:
- Millan, Mark J.
Publication type:
Article
Glutamate receptor subtypes: promising new pharmacotherapeutic targets.
Published in:
2005
By:
- Higgins, Guy A.;
- Miczek, Klaus A.
Publication type:
Editorial
NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D2/3 dopamine receptor stimulation in rats.
Published in:
Psychopharmacology, 2005, v. 179, n. 1, p. 189, doi. 10.1007/s00213-005-2201-y
By:
- Biondo, Anna-Maria;
- Clements, Robert L. H.;
- Hayes, David J.;
- Eshpeter, Brendan;
- Greenshaw, Andrew J.
Publication type:
Article

Works matching IS 00333158 AND DT 2005 AND VI 179 AND IP 1

Effects of a metabotropic glutamate<sub>2/3</sub> receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.

A six-month, placebo-controlled trial ofd-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.

Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors.

Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test.

Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine.

Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats.

The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.

Effects of deletion ofgria1orgria2genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice.

Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.

Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease.

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.

Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU<sub>2/3</sub> receptor agonist LY379268.

Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task.

Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys.

Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.

The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.

Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice.

The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).

Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents.

Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson’s disease.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.

Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

Modulators of the glycine site on NMDA receptors,d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.

Glutamate receptor subtypes: promising new pharmacotherapeutic targets.

NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D<sub>2/3</sub> dopamine receptor stimulation in rats.